Increased f2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 7, 2001, Pages 1248-1252

  Klings, Elizabeth S ^a   Christman, Brian W ^b   McClung, James ^b   Stucchi, Arthur F ^b   McMahon, Lillian ^b   Brauer, Marc ^b   Farber, Harrison W ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Hemoglobin; Lung disease; Nitric oxide; Reactive oxygen species

Indexed keywords

HEMOGLOBIN; ISOPROSTANE; NITRATE; NITRIC OXIDE; PEROXYNITRITE; PROSTAGLANDIN F2; REACTIVE OXYGEN METABOLITE; ISOPROSTANE DERIVATIVE;

ACUTE CHEST SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COR PULMONALE; DISEASE MARKER; FEMALE; HUMAN; LIPID PEROXIDATION; LUNG DISEASE; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SICKLE CELL ANEMIA; VASOCONSTRICTION; ACUTE DISEASE; BLOOD; THORAX PAIN;

ACUTE DISEASE; ADULT; ANEMIA, SICKLE CELL; CHEST PAIN; F2-ISOPROSTANES; FEMALE; HUMANS; MALE; OXIDATIVE STRESS;

EID: 0035470995     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.7.2101020     Document Type: Article

References (40)

1. Pulmonary complications of sickle cell disease
2. Pulmonary complications in adults with sickle cell disease
3. Causes and outcomes of the acute chest syndrome in sickle cell disease
4. Mortality in sickle cell disease: Life expectancy and risk factors for early death
5. Endothelial cell nitric oxide production in acute chest syndrome
6. Biochemistry of nitric oxide and its redox-activated forms
7. Free radical biochemistry of nitric oxide
8. Peroxynitrite: A two-faced metabolite of nitric oxide
9. Kinetic analysis of the fate of nitric oxide synthesized by macrophages in vitro
10. Altered amount and activity of superoxide dismutase in sickle cell anemia
11. Superoxide anion is involved in the breakdown of endothelial derived relaxing factor
12. The measurement and mechanism of lipid peroxidation in biological systems
13. 2-like compounds are produced in vivo by a non-cyclooxygenase, free radical catalyzed mechanism
14. 2 isoprostanes) in carbon tetrachloride hepatotoxicity
15. 2 isoprostanes) are formed in situ on phospholipids
16. 2 isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro
17. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease
18. 2 isoprostanes in human atherosclerotic lesions
19. 2 isoprostanes) in smokers: Smoking as a cause of oxidative damage
20. 2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus
21. 2α in familial hypercholesterolemia: Evidence of oxidative stress in vivo
22. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide
23. Endothelin-1 production during the acute chest syndrome in sickle cell disease
24. 2 isoprostanes generation in isolated ferret lungs after oxidant injury or ventilated ischemia
25. The metabolites of nitric oxide in sickle cell disease
26. Mechanisms of stroke in sickle cell disease: Sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition
27. Inhibition of endothelium dependent vasorelaxation by sickle erythrocytes
28. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle cell mice but not in normal mice
29. Biomarkers of free radical damage: Applications in experimental animals and humans
30. Reactive species in sickle cell disease
31. 2α increases platelet adhesion and reduces the anti-adhesive and anti-aggregatory effects of NO
32. Management of sickle cell disease
33. Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium
34. Low plasma pre-albumin and carotenoid levels in sickle cell disease patients
35. Serum vitamin E and the sickling status in children with sickle cell anaemia
36. Relationship of plasma alpha tocopherol to index of clinical severity in individuals with sickle cell anemia
37. A decrease in irreversibly sickled erythrocytes in sickle cell anemia patients given vitamin E
38. Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress
39. Plasma levels of retinol, ascorbic acid, and alpha-tocopherol in sickle cell anemia
40. Ascorbic acid in sickle cell disease: Results of a pilot therapeutic trial